Literature DB >> 12837697

Association of 5' estrogen receptor alpha gene polymorphisms with bone mineral density, vertebral bone area and fracture risk.

Joyce B J van Meurs1, Stephanie C E Schuit, Angélique E A M Weel, Marjolein van der Klift, Arjan P Bergink, Pascal P Arp, Edgar M Colin, Yue Fang, Albert Hofman, Cornelia M van Duijn, Johannes P T M van Leeuwen, Huibert A P Pols, André G Uitterlinden.   

Abstract

This study investigates the influence of genetic variation of the estrogen receptor alpha (ESR1) gene locus on several bone parameters in 2042 individuals of The Rotterdam Study, a prospective population-based cohort study of elderly subjects. We analysed three polymorphic sites in the 5' region of the ESR1 gene; a (TA)(n)-repeat in the promoter region, and molecular haplotypes of the PvuII and XbaI RFLPs in intron 1, and inferred long-range haplotypes (LRH) thereof. We observed only three of the possible four PvuII-XbaI haplotypes in our population. A comparison with other Caucasian populations showed similar haplotype frequencies, while in Asian and African populations these were different. Linkage disequilibrium (LD) analysis between the PvuII-XbaI haplotype and the (TA)(n) repeat showed strong LD between the two sites. Reconstruction of long range haplotypes over the entire 5' region, revealed six frequent LRH. In men, we did not observe an association between the ESR1 polymorphisms studied and bone parameters. In women, we demonstrated an allele dose effect of haplotype "px" (P=0.003) and a low number of (TA)(n) repeats (P=0.008) with decreased lumbar spine bone mineral density (BMD) (4.8% lower BMD in women homozygous for haplotype "px", representing 28% of the population, compared with homozygous non-carriers) and decreased vertebral bone area (2.3% difference between extreme genotypes; P=0.016). Most importantly, we found an increased vertebral fracture risk with evidence for an allele dose effect with an odds ratio of 2.2 (95%CI 1.3-3.5) for haplotype "px", and 2.0 (1.5-3.2) for a low number of (TA)(n) repeats. The ESR1 genotype dependent fracture risk is largely independent of BMD and bone area. Combination of risk alleles at both loci by long-range haplotyping improved the associations slightly, but because of the strong LD between the two polymorphic sites, we were unable to determine if any particular polymorphic site is driving the associations found. We conclude that ESR1 polymorphism in the 5' (promoter) region is associated with vertebral fracture risk, lumbar spine BMD and vertebral bone area in postmenopausal women, but not in men. The molecular mechanism underlying this association needs further study.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12837697     DOI: 10.1093/hmg/ddg176

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  68 in total

1.  The genetics of response to estrogen treatment.

Authors:  Bente L Langdahl
Journal:  Clin Cases Miner Bone Metab       Date:  2009-01

Review 2.  A review of estrogen receptor alpha gene (ESR1) polymorphisms, mood, and cognition.

Authors:  Erin E Sundermann; Pauline M Maki; Jeffrey R Bishop
Journal:  Menopause       Date:  2010-07       Impact factor: 2.953

3.  Association of estrogen receptor alpha gene polymorphisms and lifestyle factors with calcaneal quantitative ultrasound and osteoporosis in postmenopausal Vietnamese women.

Authors:  Tran Quang Binh; Toshikatsu Shinka; Nguyen Cong Khan; Vu Thi Thu Hien; Nguyen Thi Lam; Le Bach Mai; Takuro Nakano; Masako Sei; Shigeru Yamamoto; Masayo Nakamori; Yutaka Nakahori
Journal:  J Hum Genet       Date:  2006-09-14       Impact factor: 3.172

4.  Strong association between polymorphisms in ANKH locus and skeletal size traits.

Authors:  Ida Malkin; Sergey Ermakov; Eugene Kobyliansky; Gregory Livshits
Journal:  Hum Genet       Date:  2006-04-26       Impact factor: 4.132

Review 5.  Molecular genetic studies of gene identification for osteoporosis: a 2004 update.

Authors:  Yong-Jun Liu; Hui Shen; Peng Xiao; Dong-Hai Xiong; Li-Hua Li; Robert R Recker; Hong-Wen Deng
Journal:  J Bone Miner Res       Date:  2006-10       Impact factor: 6.741

6.  Evaluation of ERα and VDR gene polymorphisms in relation to bone mineral density in Turkish postmenopausal women.

Authors:  Ozlem Kurt; Hulya Yilmaz-Aydogan; Mehmet Uyar; Turgay Isbir; Mehmet Fatih Seyhan; Ayse Can
Journal:  Mol Biol Rep       Date:  2012-02-07       Impact factor: 2.316

Review 7.  Quantitative trait loci, genes, and polymorphisms that regulate bone mineral density in mouse.

Authors:  Qing Xiong; Yan Jiao; Karen A Hasty; S Terry Canale; John M Stuart; Wesley G Beamer; Hong-Wen Deng; David Baylink; Weikuan Gu
Journal:  Genomics       Date:  2009-01-14       Impact factor: 5.736

8.  Association of oestrogen receptor alpha gene polymorphisms with postmenopausal bone loss, bone mass, and quantitative ultrasound properties of bone.

Authors:  O M E Albagha; U Pettersson; A Stewart; F E A McGuigan; H M MacDonald; D M Reid; S H Ralston
Journal:  J Med Genet       Date:  2005-03       Impact factor: 6.318

9.  Pharmacogenetic risk factors for altered bone mineral density and body composition in pediatric acute lymphoblastic leukemia.

Authors:  Mariël L te Winkel; Robert D van Beek; Sabine M P F de Muinck Keizer-Schrama; André G Uitterlinden; Wim C J Hop; Rob Pieters; Marry M van den Heuvel-Eibrink
Journal:  Haematologica       Date:  2009-12-16       Impact factor: 9.941

10.  Polymorphisms in the low-density lipoprotein receptor-related protein 5 (LRP5) gene are associated with variation in vertebral bone mass, vertebral bone size, and stature in whites.

Authors:  Serge L Ferrari; Samuel Deutsch; Urmila Choudhury; Thierry Chevalley; Jean-Philippe Bonjour; Emmanouil T Dermitzakis; Rene Rizzoli; Stylianos E Antonarakis
Journal:  Am J Hum Genet       Date:  2004-04-07       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.